Triple negative breast cancer (TNBC) is an aggressive, highly metastatic breast cancer subtype that is characterized by a lack of hormone receptors and human epidermal growth factor receptor 2 (HER2)1,2. This evidence concerns the gene ERBB2 and breast cancer.